Drug intelligence / Profile preview

Nitargal

Development stage
Unknown
Lead developer
UNITEHPROM
Modality
Small Molecules
Administration
Topical, Ophthalmic, Oral
01

Overview

Nitargal is a pharmaceutical substance developed by UNITEHPROM at the Belarusian State University (BSU). It is a coordination complex consisting of silver ions and the amino acid L-arginine. The substance is primarily utilized as an active pharmaceutical ingredient (API) for the production of medicinal products with dual therapeutic profiles. Due to the presence of silver, it exhibits broad-spectrum antimicrobial and antiseptic properties, making it effective for wound healing and the treatment of purulent-inflammatory conditions. Additionally, Nitargal serves as a nitric oxide (NO) donor; the arginine component acts as a precursor for NO production, which induces vasodilation. This mechanism has led to its investigation and application in cardiovascular medicine for the treatment of conditions such as angina pectoris and hypertension.

Brand names
Nitargal
Other names
Silver ArginateArginine Silver Nitrate complexSilver-Arginine Complex
02

Targets

Neuraminidase

Beyond the preview

Go deeper on Nitargal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitargal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call